Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling

Despite the clinical benefits of androgen deprivation therapy, most patients with advanced androgen‐dependent prostate cancer (ADPC) eventually relapse and progress to lethal androgen‐independent prostate cancer (AIPC), also termed castration‐resistant prostate cancer (CRPC). MiRNAs can be packaged...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weixi, Kong, Piaoping, Feng, Kangle, Liu, Chunhua, Gong, Xubo, Sun, Tao, Duan, Xiuzhi, Sang, Yiwen, Jiang, Yu, Li, Xiang, Zhang, Lingyu, Tao, Zhihua, Liu, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637070/
https://www.ncbi.nlm.nih.gov/pubmed/37671589
http://dx.doi.org/10.1111/cas.15948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637070/
https://www.ncbi.nlm.nih.gov/pubmed/37671589
http://dx.doi.org/10.1111/cas.15948

Ejemplares similares